Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241914543 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Alan Rubén Estrada-Pérez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Diseño y Desarrollo de Nuevos Fármacos e Innovación Biotecnológica, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan…. Hauptthemen laut MEDLINE: Breast Neoplasms, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología, Instituto Politécnico Nacional, Secretaría de Investigación y Posgrado (SIP) of the Instituto Politécnico Nacional (IPN).
Abstract (Originalsprache)
Breast cancer (BC) is one of the biggest health problems worldwide, characterized by intricate metabolic and biochemical complexities stemming from pronounced variations across dysregulated molecular pathways. If BC is not diagnosed early, complications may lead to death. Thus, the pursuit of novel therapeutic avenues persists, notably focusing on epigenetic pathways such as histone deacetylases (HDACs). The compound N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA), a derivative of valproic acid (VPA), has emerged as a promising candidate warranting pre-clinical investigation. HO-AAVPA is an HDAC inhibitor with antiproliferative effects on BC, but its molecular mechanism has yet to be deciphered. Furthermore, in the present study, we determined the metabolomic effects of HO-AAVPA and VPA on cells of luminal breast cancer (MCF-7) and triple-negative breast cancer (MDA-MB-231) subtypes. The LC-MS untargeted metabolomic study allowed for the simultaneous measurement of multiple metabolites and pathways, identifying that both compounds affect glycerophospholipid and sphingolipid metabolism in the MCF-7 and MDA-MB-231 cell lines, suggesting that other biological targets were different from HDACs. In addition, there are different dysregulate metabolites, possibly due to the physicochemical differences between HO-AAVPA and VPA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Diseño y Desarrollo de Nuevos Fármacos e Innovación Biotecnológica, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Casco de Santo Tomás, Ciudad de México…
- Laboratorio de Biofísica y Biocatálisis, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Casco de Santo Tomás, Ciudad de…
ORCID-Profile: Alan Rubén Estrada-Pérez, Juan Benjamín García-Vázquez, Humberto L Mendoza-Figueroa, Martha Cecilia Rosales-Hernández, José Correa-Basurto
Förderung
- Consejo Nacional de Ciencia y Tecnología
- Instituto Politécnico Nacional
- Secretaría de Investigación y Posgrado (SIP) of the Instituto Politécnico Nacional (IPN)
- Proyecto de innovación
- CONACYT programs
Zitieren
APA
Estrada-Pérez, A. R., García-Vázquez, J. B., Mendoza-Figueroa, H. L., Rosales-Hernández, M. C., Fernández-Pomares, C., & Correa-Basurto, J. (2023). Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914543
Vancouver
Estrada-Pérez AR, García-Vázquez JB, Mendoza-Figueroa HL, Rosales-Hernández MC, Fernández-Pomares C, Correa-Basurto J. Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914543
BibTeX
@article{EstradaPrez2023,
author = {Estrada-Pérez, Alan Rubén and García-Vázquez, Juan Benjamín and Mendoza-Figueroa, Humberto L and Rosales-Hernández, Martha Cecilia and Fernández-Pomares, Cynthia and Correa-Basurto, José},
title = {Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241914543}
}
EUVIMED